“…Evidence is accumulating that a human ortholog of Fmi, CELSR3, is expressed at high levels in a range of solid tumors, including lung, prostate, pancreatic, hepatic, ovarian and colorectal cancers, and in some cases has been shown to be associated with poor prognosis (Katoh & Katoh, 2007; Erkan et al, 2010; Asad et al, 2014; Goryca et al, 2018; Li et al, 2021; Chen et al, 2021a). Recently, CELSR1 upregulation has also been linked to poor ovarian cancer prognosis, likely by promoting proliferation, migration, and invasion (Zuo et al, 2023). If CELSR1/3 are promoting winner cell behavior in these tumors, as might be predicted from its function in Drosophila , this could provide the rationale for future efforts to understand the mechanism by which Fmi/CELSR3 facilitates cell competition, with the goal of identifying an intervention that could blunt or perhaps even eliminate the aggressiveness of an array of highly morbid cancers.…”